Related Experiment Videos
Balloon alignment T-stenting for bifurcation coronary artery disease using the sirolimus-eluting stent
David G Rizik1, Kevin J Klassen, Denise A Dowler
1Scottsdale Heart Group at Scottsdale Healthcare Hospital, 9755 North 90th Street, A-100, Scottsdale, AZ 85259, USA. davidrizik@aol.com
Insights
This pilot study evaluated balloon alignment T-stenting for coronary artery disease. The novel technique showed promising results with no main branch restenosis and a low side branch restenosis rate.
Area of Science:
- Interventional Cardiology
- Vascular Medicine
- Biomedical Engineering
Background:
- Optimal treatment strategies for coronary artery disease at bifurcations remain debated.
- Novel stenting techniques are needed to improve patient outcomes.
Purpose of the Study:
- To assess the long-term efficacy and safety of the "balloon alignment T-stenting" technique.
- To evaluate restenosis rates in main and side branches after treatment.
Main Methods:
- A pilot study involving 26 patients with bifurcation coronary lesions.
- Treatment utilized drug-eluting stent (DES) platforms with the novel "balloon alignment T-stenting" technique.
- Six-month follow-up angiography was performed to assess restenosis.
Main Results:
- No postprocedural mortality or stent thrombosis observed.
- Zero restenosis in treated main branches.
- A 7.4% restenosis rate in side branches.
- 7.6% target lesion revascularization rate.
- 15.4% major adverse cardiac event rate.
Conclusions:
- Balloon alignment T-stenting may be a viable approach for treating coronary artery bifurcations using current DES.
- Further large-scale trials are necessary to confirm these preliminary findings.
Objective:
The purpose of this study was to evaluate the long-term outcomes of bifurcation coronary lesions treated with a novel technique called "balloon alignment T-stenting".
Background:
The optimal technique for the treatment of bifurcation coronary disease has not yet been established.
Methods:
Twenty-six patients with bifurcation coronary lesions were treated with currently available drug-eluting stent (DES) platforms. This was a pilot study to determine the long-term efficacy of a novel technique, "balloon alignment T-stenting". Based on this technique we performed 6-month anniversary angiography to determine restenosis rates for both main and side branch lesions treated.
Results:
Twenty-six main branches and 27 side branches were treated with this novel technique. Angiographic 6-month follow up was available for all 26 patients treated. There were no postprocedural mortalities and no cases of postprocedural stent thrombosis during the follow-up period. At 6-month anniversary angiography, no evidence of main branch restenosis was seen. However, there were 2 cases of side branch restenosis for a total side branch restenosis rate of 7.4%. Target lesion revascularization for the 26 patients in the study was 7.6%. The total major adverse cardiac event rate for the group as a whole was 15.4%, with 2 periprocedural non-Q-wave myocardial infarctions and 2 target lesions requiring revascularization at 6 months.
Conclusion:
Using currently available DES platforms, the data compiled from this small, single-center pilot study suggest that balloon alignment T-stenting may represent a reasonable approach for the treatment of bifurcation coronary artery disease. However, more comprehensive, larger-scale trials will be required to validate these preliminary findings.
